XBKK
RAM
Market cap653mUSD
Nov 12, Last price
18.30THB
Name
Ramkhamhaeng Hospital PCL
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ramkhamhaeng Hospital Public Company Limited and its associated entities provide healthcare services through their private hospital network throughout Thailand. The hospital complex comprises three patient buildings, collectively offering approximately 485 beds. Additionally, the company is involved in the sale of medical equipment and instruments. Established in 1988, its headquarters are situated in Bangkok, Thailand.
Key people
Pumipat Chatnoraset
Chief Financial Officer · since 2026
Surabot Visutimatakul
Chief Financial Officer
Pramuk Unachak
Executive Vice President - Northern Hospital Group, Executive Director · since 2024
Jermpol Bhumitrakul
Group Chief Operating Officer, Chief Affiliate Hospital Group 1, Executive Director · since 2024
Talit Chuen-Im
Executive Vice President - Northeastern Hospital Group, Executive Director · since 2024
Rukkagee Kanjanapitak
Group Chief Executive Officer, Executive Director · since 2024
Suthee Leelasetakul
Executive Director, Chief Executive Officer, RAM 1 · since 2023
Siripong Luengvarinkul
Executive Director, Chief Affiliate Hospital Group 2 · since 2023
Executive Chairman of the Board · since 2024
Company Secretary · since 2025
Director · since 2025
Benny Lim
Director · since 2019
Wiroj Onganunkun
Director · since 2025
Tassawan Sirivongs
Director · since 2024
Kajit Habanananda
Independent Director · since 2021
Pinit Hirunyachote
Independent Director · since 2015
Kittiyarat Jirojdamrongchai
Independent Director · since 2007
Somsri Pausawasdi
Independent Director · since 2022
Independent Director · since 2025
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||